References

  1. Projahn D, Koenen RR: Platelets. key players in vascular inflammation. J Leukoc Biol. 2012; 92(6): 1167-1175. PubMed | Google Scholar

  2. Ware J, Corken A, Khetpal R. Platelet function beyond hemostasis and thrombosis. Curr Opin Hematol. 2013; 20(5):451-456. PubMed | Google Scholar

  3. Berndt MC, Metharom P, Andrews RK. Primary haemostasis: newer insights. Haemophilia. 2014;20(4):15-22. PubMed | Google Scholar

  4. Huang HS, Chang HH. Platelets in inflammation and immune modulations: functions beyond hemostasis. Arch Immunol Ther Exp (Warsz). 2012; 60(6): 443-451. PubMed | Google Scholar

  5. Briggs C.Quality counts: new parameters in blood cell counting. Int J Lab Hematol. 2009; 31(3): 277-297. PubMed | Google Scholar

  6. Chu SG, Becker RC, Berger PB et al. Mean platelet volume as a predictor of cardiovascular risk: a systematic review and meta-analysis. J Thromb Haemost. 2010; 8(1): 148-156. PubMed | Google Scholar

  7. Zhang Z, Xu X, Ni H, Deng H. Platelet indices are novel predictors of hospital mortality in intensive care unit patients. J Crit Care. 2014; 29(5):885e1-6. PubMed | Google Scholar

  8. Ozturk ZA, Dag MS, Kuyumcu ME et al. Could platelet indices be new biomarkers for inflammatory bowel diseases? Eur Rev Med Pharmacol Sci. 2013; 17(3): 334-41. PubMed | Google Scholar

  9. Rose SR, Petersen NJ, Gardner TJ et al. Etiology of thrombocytosis in a general medicine population: analysis of 801 cases with emphasis on infectious causes. J Clin Med Res. 2012;4(6): 415-423. PubMed | Google Scholar

  10. Aydogan T, Kanbay M, Alici O et al.Incidence and etiology of thrombocytosis in an adult Turkish population. Platelets. 2006; 17(5): 328-331. PubMed | Google Scholar

  11. Santimone I, Di Castelnuovo A, De Curtis A et al. MOLI-SANI Project Investigators: White blood cell count, sex and age are major determinants of heterogeneity of platelet indices in an adult general population: results from the MOLI-SANI project. Haematologica. 2011; 96(8):1180-1188. PubMed | Google Scholar

  12. Zareifar S, Farahmand Far MR, Golfeshan F et al. Changes in platelet count and mean platelet volume during infectious and inflammatory disease and their correlation with ESR and CRP. J Clin Lab Anal. 2014; 28(3): 245-248. PubMed | Google Scholar

  13. Avcioglu SN, Altinkaya SO, Kucuk M et al. Can platelet indices be new biomarkers for severe endometriosis? ISRN Obstet Gynecol. 2014; 2014: 713542. PubMed | Google Scholar

  14. Li B, Liu X, Cao ZG et al. Elevated mean platelet volume is associated with silent cerebral infarction. Intern Med J. 2014; 44(7): 653-657. PubMed | Google Scholar

  15. Dalamaga M, Karmaniolas K, Lekka A et al. Platelet markers correlate with glycemic indices in diabetic, but not diabetic-myelodysplastic patients with normal platelet count. Dis Markers. 2010; 29(1): 55-61. PubMed | Google Scholar

  16. Jabeen F, Fawwad A, Rizvi HA et al. Role of platelet indices, glycemic control and hs-CRP in pathogenesis of vascular complications in type-2 diabetic patients. Pak J Med Sci. 2013; 29(1): 152-156. PubMed | Google Scholar

  17. Sahin F, Yazar E, Yildiz P. Prominent features of platelet count, plateletcrit, mean platelet volume and platelet distribution width in pulmonary tuberculosis. Multidiscip Respir Med. 2012; 7(1): 38. PubMed | Google Scholar

  18. Gunluoglu G, Yazar EE, Veske NS et al. Mean platelet volume as an inflammation marker in active pulmonary tuberculosis. Multidiscip Respir Med. 2014; 9(1): 11. PubMed | Google Scholar

  19. Smyth SS, McEver RP, Weyrich AS et al. 2009 Platelet Colloquium Participants: Platelet functions beyond hemostasis. J Thromb Haemost. 2009; 7(11):1759-1766. PubMed | Google Scholar

  20. Gao Y, Li Y, Yu X et al. The impact of various platelet indices as prognostic markers of septic shock. PLoS One. 2014; 9(8): e103761. PubMed | Google Scholar

  21. deStoppelaar SF, van 't Veer C, van der Poll T.The role of platelets in sepsis. Thromb Haemost. 2014;112(4): 666-677. PubMed | Google Scholar

  22. Carobbio A, Antonioli E, Guglielmelli P et al. Leukocytosis and risk stratification assessment in essential thrombocythemia. J Clin Oncol. 2008; 26(16): 2732-2736. PubMed | Google Scholar

  23. De Stefano V, Za T, Rossi E et al.GIMEMA Chronic Myeloproliferative Neoplasms Working Party: Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia. Am J Hematol. 2010;85(2):97-100.. PubMed | Google Scholar